Skip to main content
OpenTrials

Clinical trial condition

Oligodendroglioma

Explore clinical trials studying Oligodendroglioma. Study availability and eligibility vary by location and protocol.

299 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Oligodendroglioma trial results

Active, Not Recruiting

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

NCT02381886

Conditions
Adenocarcinoma, Advanced Malignancies That Harbor IDHR132 Mutations, Astrocytoma, +19 more
Locations
  • Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center- New York Presbyterian Onc Dept. New York, United States
  • Columbia University Medical Center New York, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

NCT05484622

Conditions
Astrocytoma, Glioma, Neoplasms, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles (Site: 840113) Los Angeles, California, United States
  • University of California, San Francisco (Site: 840149) San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

NCT03152318

Conditions
Anaplastic Oligodendroglioma of Brain (Diagnosis), Astrocytoma, Brain Cancer, +28 more
Locations
  • Johns Hopkins University Medical Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

NCT00887146

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 291 locations
View Trial Details
Active, Not Recruiting

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

NCT00978458

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States
View all 168 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma

NCT05561374

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +10 more
Locations
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • The University of Oklahoma Health Sciences Center, Stephenson Cancer Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)

NCT00626990

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +12 more
Locations
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCSF University of California San Francisco Medical Center-Mount Zion San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
View all 132 locations
View Trial Details

Related conditions